KFDA to examine adverse reactions with Champix

Published: 2008-01-15 06:59:00

Updated: 2008-01-15 06:59:00

The Korea Food and Drug Administration says that it instructed Pfizer Korea to include adverse reactions of its smoking cessation drug Champix to an insert paper.

Champix has been in the news a bit recently as there have been a number of reports saying that it can cause depression and even sui...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK